Sophia Hober

Q: What Schools Are Affiliated With Sophia Hober

Sophia Hober is affiliated with the following schools: University of California, Berkeley, Uppsala University, KTH Royal Institute of Technology, Stanford University

Sophia Hober's AcademicInfluence.com Rankings

Sophia Hober

Computer Science

#10935

World Rank

#11531

Historical Rank

Machine Learning

#4993

World Rank

#5054

Historical Rank

Artificial Intelligence

#5375

World Rank

#5448

Historical Rank

Database

#7952

World Rank

#8282

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Sophia Hober's Degrees

Masters Computer Science Stanford University
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Sophia Hober Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sophia Hober is a Swedish researcher in biotechnology and professor at The Royal Institute of Technology in Stockholm. Sophia Hober got her Master of Science in chemical engineering at KTH in 1989 and defended her doctorate in biochemistry in 1996. Since 2007, Hober is a professor of molecular biotechnology at KTH. During 2011–2015, Professor Hober served as dean at KTH and was part of the management team. Sophia Hober was elected member of the Royal Swedish Academy of Engineering Sciences in 2012.

(See a Problem?)

Sophia Hober's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tissue-based map of the human proteome (2015) (9179)
Towards a knowledge-based Human Protein Atlas (2010) (2114)
A pathology atlas of the human cancer transcriptome (2017) (2109)
A subcellular map of the human proteome (2017) (1796)
A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics* (2005) (1280)
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies* (2008) (599)
Protein A chromatography for antibody purification. (2007) (446)
Pyrosequencing: history, biochemistry and future. (2006) (356)
Towards a human proteome atlas: High‐throughput generation of mono‐specific antibodies for tissue profiling (2005) (271)
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden (2020) (222)
Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers Sebastian Haverall, Axel Rosell, Mia Phillipson, et al JAMA. 2021;325(19):2015-2016. (2021) (219)
A global view of protein expression in human cells, tissues, and organs (2009) (204)
The human secretome (2019) (174)
The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD. (2007) (117)
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial (2021) (109)
The Impact of Tissue Fixatives on Morphology and Antibody-based Protein Profiling in Tissues and Cells (2010) (106)
Structure, Specificity, and Mode of Interaction for Bacterial Albumin-binding Modules* (2002) (106)
Improving the tolerance of a protein a analogue to repeated alkaline exposures using a bypass mutagenesis approach (2004) (96)
Enhancing the protein production levels in Escherichia coli with a strong promoter (2011) (89)
MAP20, a Microtubule-Associated Protein in the Secondary Cell Walls of Hybrid Aspen, Is a Target of the Cellulose Synthesis Inhibitor 2,6-Dichlorobenzonitrile1[W][OA] (2008) (86)
Disulfide exchange folding of insulin-like growth factor I. (1992) (80)
The albumin-binding domain as a scaffold for protein engineering (2013) (79)
A human protein atlas based on antibody proteomics. (2006) (73)
High-throughput protein purification using an automated set-up for high-yield affinity chromatography. (2006) (71)
Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m (2017) (70)
Selective enrichment of monospecific polyclonal antibodies for antibody-based proteomics efforts. (2004) (64)
Protein engineering of an IgG-binding domain allows milder elution conditions during affinity chromatography. (2000) (63)
Mutational analysis of the interaction between albumin‐binding domain from streptococcal protein G and human serum albumin (2002) (63)
Engineering streptococcal protein G for increased alkaline stability. (2002) (62)
Enhanced validation of antibodies for research applications (2018) (62)
A Web-based Tool for in Silico Biomarker Discovery Based on Tissue-specific Protein Profiles in Normal and Cancer Tissues*S (2008) (61)
High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer (2011) (56)
Human protein atlas and the use of microarray technologies. (2008) (55)
Contribution of antibody-based protein profiling to the human Chromosome-centric Proteome Project (C-HPP). (2013) (54)
Antibody performance in western blot applications is context-dependent. (2014) (51)
Charge engineering of a protein domain to allow efficient ion-exchange recovery. (2000) (50)
Developments in biobanking workflow standardization providing sample integrity and stability. (2013) (50)
Generation and validation of affinity reagents on a proteome‐wide level (2009) (49)
Protein Engineering Strategies for Selective Protein Purification (2005) (48)
Affibody-mediated transferrin depletion for proteomics applications. (2007) (47)
High‐throughput protein production – Lessons from scaling up from 10 to 288 recombinant proteins per week (2009) (47)
Stability towards alkaline conditions can be engineered into a protein ligand. (2000) (45)
Engineering of Bispecific Affinity Proteins with High Affinity for ERBB2 and Adaptable Binding to Albumin (2014) (45)
Covalent immunoglobulin labeling through a photoactivable synthetic Z domain. (2011) (45)
ADAPT, a Novel Scaffold Protein-Based Probe for Radionuclide Imaging of Molecular Targets That Are Expressed in Disseminated Cancers. (2015) (44)
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2 (2021) (43)
A novel flow cytometry-based method for analysis of expression levels in Escherichia coli, giving information about precipitated and soluble protein. (2005) (43)
Folding of insulin-like growth factor I is thermodynamically controlled by insulin-like growth factor binding protein. (1994) (41)
Engineering Bispecificity into a Single Albumin-Binding Domain (2011) (40)
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19 (2021) (35)
Immunoproteomics Using Polyclonal Antibodies and Stable Isotope–labeled Affinity-purified Recombinant Proteins* (2014) (35)
Z(basic)--a novel purification tag for efficient protein recovery. (2007) (34)
Influence of Histidine-Containing Tags on the Biodistribution of ADAPT Scaffold Proteins. (2016) (34)
Multiplexed PrEST immunization for high-throughput affinity proteomics. (2006) (34)
A small bispecific protein selected for orthogonal affinity purification (2010) (33)
Quantum Dot-Based FRET Immunoassay for HER2 Using Ultrasmall Affinity Proteins. (2018) (33)
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys (2021) (32)
Radionuclide Tumor Targeting Using ADAPT Scaffold Proteins: Aspects of Label Positioning and Residualizing Properties of the Label (2018) (31)
Affinity ligands for industrial protein purification. (2005) (30)
Development and characterization of small bispecific albumin-binding domains with high affinity for ErbB3 (2013) (30)
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection (2022) (29)
Disulfide exchange folding of disulfide mutants of insulin-like growth factor I in vitro. (1997) (29)
Development of Humoral and Cellular Immunological Memory Against SARS-CoV-2 Despite B-Cell Depleting Treatment in Multiple Sclerosis (2021) (28)
Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer (2020) (27)
Integrated chromosome 19 transcriptomic and proteomic data sets derived from glioma cancer stem-cell lines. (2014) (27)
Association of chromosome 19 to lung cancer genotypes and phenotypes (2015) (27)
Approaches for systematic proteome exploration. (2007) (27)
Integrated strategy for selective expanded bed ion-exchange adsorption and site-specific protein processing using gene fusion technology. (2002) (27)
Tissue Profiling of the Mammalian Central Nervous System Using Human Antibody-based Proteomics* (2009) (26)
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection (2021) (25)
Genome‐based proteomics (2004) (25)
From Gene Expression Analysis to Tissue Microarrays (2006) (25)
Strategy for highly selective ion-exchange capture using a charge-polarizing fusion partner. (2002) (24)
Single‐step recovery and solid‐phase refolding of inclusion body proteins using a polycationic purification tag (2006) (24)
Evaluation of Monospecific Antibodies: A Comparison Study With Commercial Analogs Using Immunohistochemistry on Tissue Microarrays (2008) (24)
Insulin‐like growth factors I and II are unable to form and maintain their native disulfides under in vivo redox conditions 1 (1999) (23)
Development of affinity columns for the removal of high‐abundance proteins in cerebrospinal fluid (2009) (23)
Microfluidic analysis of antibody specificity in a compact disk format. (2006) (23)
Escherichia coli single‐stranded DNA‐binding protein, a molecular tool for improved sequence quality in pyrosequencing (2002) (22)
SARS-CoV-2 exposure, symptoms and seroprevalence in health care workers (2020) (21)
Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome. (2015) (21)
Methylotrophic yeast Pichia pastoris as a host for production of ATP-diphosphohydrolase (apyrase) from potato tubers (Solanum tuberosum). (2003) (20)
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients (2021) (20)
High-throughput solubility assay for purified recombinant protein immunogens. (2005) (20)
Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assay (2021) (20)
Affinity Fusions, Gene Expression (2002) (19)
Negatively charged purification tags for selective anion-exchange recovery. (2004) (19)
Overexpression, rapid isolation, and biochemical characterization of Escherichia coli single-stranded DNA-binding protein. (2001) (18)
Chromosome 19 annotations with disease speciation: a first report from the Global Research Consortium. (2013) (18)
Effect of substrate feed rate on recombinant protein secretion, degradation and inclusion body formation in Escherichia coli (2005) (18)
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis (2021) (18)
In vivo biotinylation and incorporation of a photo-inducible unnatural amino acid to an antibody-binding domain improve site-specific labeling of antibodies. (2015) (18)
Protein Engineering Allows for Mild Affinity-based Elution of Therapeutic Antibodies. (2018) (18)
Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2‐expressing tumours (2019) (17)
MAP 20 , a Microtubule-Associated Protein in the Secondary Cell Walls of Hybrid Aspen , Is a Target of the Cellulose Synthesis Inhibitor 2 , 6-Dichlorobenzonitrile 1 [ W ] [ OA ] (2008) (17)
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection (2022) (16)
Next generation of labeling reagents for quantitative and multiplexing immunoassays by the use of LA-ICP-MS. (2016) (16)
Site-Specific Photolabeling of the IgG Fab Fragment Using a Small Protein G Derived Domain. (2016) (16)
Evaluation of different linker regions for multimerization and coupling chemistry for immobilization of a proteinaceous affinity ligand. (2003) (15)
Characterization of PrEST-based antibodies towards human Cytokeratin-17. (2009) (15)
Purification Systems Based on Bacterial Surface Proteins (2012) (15)
Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time (2022) (15)
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals (2022) (15)
Optimization of a calcium-dependent Protein A-derived domain for mild antibody purification (2019) (14)
Parallel production and verification of protein products using a novel high-throughput screening method. (2011) (14)
Development of affinity columns for the removal of high-abundance proteins in cerebrospinal fluid. (2009) (14)
Bispecific applications of non-immunoglobulin scaffold binders. (2019) (14)
Insulin-like growth factors I and II are unable to form and maintain their native disulfides under in vivo redox conditions. (1999) (13)
High throughput generation of a resource of the human secretome in mammalian cells. (2020) (13)
Expression and characterization of a tripartite fusion protein consisting of chimeric IgG-binding receptors and β-galactosidase (1990) (13)
Antibodies as means for selective mass spectrometry. (2016) (13)
False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases (2021) (13)
Kinetic characterization of the interaction of the Z‐fragment of protein A with mouse‐IgG3 in a volume in chemical space (1999) (13)
Affibody molecule‐mediated depletion of HSA and IgG using different buffer compositions: a 15 min protocol for parallel processing of 1–48 samples (2010) (13)
Selection of the optimal macrocyclic chelators for labeling with 111In and 68Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6. (2019) (13)
The human secretome – the proteins secreted from human cells (2018) (12)
Systematically generated antibodies against human gene products: High throughput screening on sections from the rat nervous system (2007) (12)
Influence of the N-Terminal Composition on Targeting Properties of Radiometal-Labeled Anti-HER2 Scaffold Protein ADAPT6. (2016) (12)
Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care (2021) (11)
Surrogate antigens as targets for proteome-wide binder selection. (2011) (11)
Enzymatic cleavage of fusion proteins using immobilised protease 3C. (2006) (11)
Optimized Molecular Design of ADAPT-Based HER2-Imaging Probes Labeled with 111In and 68Ga. (2018) (11)
Differences in risk for SARS-CoV-2 infection among healthcare workers (2021) (11)
Orthogonal Protein Purification Facilitated by a Small Bispecific Affinity Tag (2012) (10)
Miniaturized and automated high-throughput verification of proteins in the ISET platform with MALDI MS. (2012) (10)
Investigating the applicability of antibodies generated within the human protein atlas as capture agents in immunoenrichment coupled to mass spectrometry. (2014) (10)
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines (2022) (10)
Potent and specific fusion toxins consisting of a HER2‑binding, ABD‑derived affinity protein, fused to truncated versions of Pseudomonas exotoxin A. (2019) (10)
An improved dual‐expression concept, generating high‐quality antibodies for proteomics research (2003) (10)
Phenotypic Screen with the Human Secretome Identifies FGF16 as Inducing Proliferation of iPSC-Derived Cardiac Progenitor Cells (2019) (10)
Secretome-Based Screening in Target Discovery (2020) (10)
High‐throughput protein purification under denaturating conditions by the use of cation exchange chromatography (2007) (10)
High rate of BA.1, BA.1.1 and BA.2 infection in triple vaccinated (2022) (9)
Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle. (2020) (8)
Antibodies to SARS-CoV-2 and risk of past or future sick leave (2021) (8)
High amounts of SARS-CoV-2 precede sickness among asymptomatic healthcare workers (2021) (8)
Highly selective Protein A resin allows for mild sodium chloride-mediated elution of antibodies. (2020) (7)
B‐cell repopulation dynamics and drug pharmacokinetics impact SARS‐CoV‐2 vaccine efficacy in anti‐CD20‐treated multiple sclerosis patients (2022) (7)
Affinity-Based Methods for Site-Specific Conjugation of Antibodies (2021) (7)
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection (2023) (6)
HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution (2020) (6)
Design of an integrated continuous downstream process for acid-sensitive monoclonal antibodies based on a calcium-dependent Protein A ligand (2022) (6)
Investigating affinity-maturation strategies and reproducibility of fluorescence-activated cell sorting using a recombinant ADAPT library displayed on staphylococci. (2016) (5)
Integrated continuous biomanufacturing on pilot scale for acid‐sensitive monoclonal antibodies (2022) (5)
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses (2021) (5)
Neutralization of VOCs including Delta one year post COVID-19 or vaccine (2021) (5)
Toward pyrosequencing on surface-attached genetic material by use of DNA-binding luciferase fusion proteins. (2004) (5)
A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells (2022) (5)
Long‐term SARS‐CoV‐2‐specific and cross‐reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology (2022) (4)
Engineering of Protein A for improved purification of antibodies and Fc-fused proteins (2020) (4)
Secretome screening reveals immunomodulating functions of IFNα-7, PAP and GDF-7 on regulatory T-cells (2021) (4)
Improvements of a high-throughput protein purification process using a calcium-dependent setup. (2020) (4)
Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein (2021) (4)
Antibodies Biotinylated Using a Synthetic Z-domain from Protein A Provide Stringent In Situ Protein Detection (2013) (4)
Novel antigen design for the generation of antibodies to G-protein-coupled receptors. (2011) (3)
Translational Database Selection and Multiplexed Sequence Capture for Up Front Filtering of Reliable Breast Cancer Biomarker Candidates (2011) (3)
SARS-CoV-2 serological tests can generate false positive results for samples from patients with chronic inflammatory diseases (2020) (3)
Small Bispecific Affinity Proteins for Simultaneous Target Binding and Albumin-Associated Half-Life Extension (2020) (3)
Antibodies to SARS-CoV-2 and risk of future sickness (2020) (3)
A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies (2021) (3)
SARS‐CoV‐2 infections amongst personnel providing home care services for older persons in Stockholm, Sweden (2021) (3)
Automated sample preparation method for mass spectrometry analysis on recombinant proteins. (2009) (3)
Development of ADAPT6 as a new scaffold protein for radionuclide molecular imaging (2014) (2)
Screening for high amounts of SARS-CoV-2 identifies pre-symptomatic subjects among healthy healthcare workers (2020) (2)
Expression and characterization of a tripartite fusion protein consisting of chimeric IgG-binding receptors and beta-galactosidase. (1990) (2)
High rate of BA.1, BA.1.1 and BA.2 in triple vaccinated (2022) (2)
Investigation of a Pharmacological Approach for Reduction of Renal Uptake of Radiolabeled ADAPT Scaffold Protein (2020) (2)
CaRA - A Multi-Purpose Phage Display Library for Selection of Calcium-Regulated Affinity Proteins. (2022) (2)
SARS-CoV-2 infections among personnel providing home care services for the elderly in Stockholm, Sweden (2020) (2)
Erratum to: Association of chromosome 19 to lung cancer genotypes and phenotypes (2015) (1)
An orthogonal fusion tag for efficient protein purification. (2014) (1)
Editorial: Biotech reviews – keeping up with current developments (2011) (1)
Discovery of breast cancer biomarker candidates by translational database selection and multiplex enrichment strategies (2010) (1)
High throughput protein production and purification in the Human Protein Atlas program (2006) (1)
Impact of SARS-CoV-2 infection on longitudinal vaccine immune responses (2021) (1)
Targeted protein pullout from human tissue samples using competitive elution. (2011) (1)
An Orthogonal Fusion Tag for Efficient Protein Purification. (2020) (1)
Zbasic: a purification tag for selective ion-exchange recovery. (2014) (1)
In-depth study of the positive effects of Escherichia coli Rosetta(DE3) on recombinant protein production (2013) (1)
Affibody molecule mediated depletion of HSA and IgG performed in singlet or in a rapid high throughput format (2009) (0)
Editorial: Global biotech challenges (2010) (0)
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose (2023) (0)
Editorial: Biotech reviews on plants, lignocellulose, sequencing, genome engineering and Aspergilli (2012) (0)
Correction to: Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys (2022) (0)
Towards an immunobased tool for the qualification of bookmarker candidates-compact disk enclosed nanocolumns with orientation-immobilized monospecific antibodies. (2010) (0)
Appearance of IgG to SARS-CoV-2 in saliva effectively indicates seroconversion in mRNA vaccinated immunocompromised individuals (2021) (0)
Generation of validated antibodies towards the human proteome (2008) (0)
Paired antibodies for multi-application validation of antibody specificity (2009) (0)
Engineering of bispecific affinity proteins with nanomolar affinity for both ErbB2 and albumin (2012) (0)
A method for affinity separation and ligands for pertinent use (1999) (0)
Correction to “Small Bispecific Affinity Proteins for Simultaneous Target Binding and Albumin-Associated Half-Life Extension” (2022) (0)
Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart (2022) (0)
Zbasic: A Purification Tag for Selective Ion-Exchange Recovery. (2020) (0)
Antibodies biotinylated using a synthetic Z-domain provide stringent in situ proteindetection (2012) (0)
Ultrasmall Affinity Proteins for Highly Sensitive Quantum Dot FRET Immunoassays (2018) (0)
Flow cytometry-based analysis of promoter effects on solubility of recombinantly expressed proteins (2007) (0)
Development and characterization of small bispecific albumin-binding domains with high affinity for ErbB3 (2013) (0)
The correlation between antigen solubility and immunogenicity (2010) (0)
ZCa: A Protein A-Derived Domain with Calcium-Dependent Affinity for Mild Antibody Purification. (2021) (0)
Development and characterization of small bispecific three-helical ErbB3/albumin-binding domains aimed at therapeutic applications (2012) (0)
An engineered Protein A derived domain for calcium dependent elution in antibody purification (2016) (0)
Fc in complex with engineered calcium binding domain Z (2018) (0)
Editorial Board: Biotechnology Journal 2/2019 (2019) (0)
A binding protein mutated immunoglobulin (2003) (0)
Performan e Analysis and Design of STBC ' s forFrequen y { Sele tive Fading Channels (2001) (0)
Novel antigen design for the generation of G-protein-coupled receptorantibodies. (2010) (0)
Deciphering the determinants of recombinant protein yield across the human secretome (2022) (0)
Enhanced validation of antibodies for research applications (2018) (0)
Calcium-dependent affinity ligands for the purification of antibody fragments at neutral pH. (2023) (0)
Editorial Board: Biotechnology Journal 1/2019 (2019) (0)
Editorial: Biotech in the post genomic era (2009) (0)
Selection of the optimal macrocyclic chelators for labelling with In-111 and Ga-68 improves contrast of HER2 imaging using engineered scaffold protein ADAPT6 (2019) (0)
VINN Excellence Centre for Protein Technology Project Status Reports (2010) (0)
Editorial Board: Biotechnology Journal 1/2018 (2018) (0)
Optimization of an antibody labeling strategy through the use of photoactivable synthetic Z domains (2012) (0)
Ubiquitous protein expression in human cells, tissues and organs (2008) (0)
Investigating the correlation of protein and mRNA levels in human cell lines using quantitative proteomics and transcriptomics (2014) (0)
The GRPR Antagonist [99mTc]Tc-maSSS-PEG2-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity (2023) (0)
Influence of the N-terminal amino acid sequence on imaging properties of In-111-labeled anti-HER2 scaffold protein ADAPT6 (2016) (0)
ADAPT as a single-domain bispecific scaffold capable of albumin-associated haf-life extension for therapeutic applications (2020) (0)
Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m (2017) (0)
Biotech reviews on plants, lignocellulose, sequencing, genome engineering and Aspergilli (2012) (0)
IGF-BP Use of IGF refolding (1996) (0)
High throughput antibody generation and validation for antibody proteomics (2005) (0)
Stable IgG-antibody levels in patients with mild SARS-CoV-2 infection (2021) (0)
Selection of the most optimal ADAPT6-based probe for imaging of HER2 using PET and SPECT (2018) (0)
Editorial Board: Biotechnology Journal 10/2017 (2017) (0)
Calcium-dependent protein folding in a designed molecular switch. (2023) (0)
Direct In Vivo Comparison of 99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy (2022) (0)
Antigenic mapping and characterization of Albumin Binding Protein (2010) (0)
Influence of Histidine-Containing Tags on Biodistribution of Radiolabelled ADAPT-Based Imaging Probes (2015) (0)
Genetic Approaches to Facilitate Protein Puri.cation (2003) (0)
Antibody Proteomics to Explore the Human Proteome (2004) (0)
Association of chromosome 19 to lung cancer genotypes and phenotypes (2015) (0)
Engineering bispecificity into a single albumin-binding domain aimed for drug targeting and in vivo half-life extension (2013) (0)
Solution structure of the Albumin binding domain of Streptococcal Protein G (2001) (0)
Novel universal SARS-CoV DNA vaccine inducing neutralizing antibodies to huCoV-19/WH01, Beta, Delta and Omicron variants and T cells to Bat-CoV (2022) (0)
Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers (2023) (0)
5 Purification Systems Based on Bacterial Surface Proteins (2012) (0)
Binding protein mutated immunoglobulins (2003) (0)

This paper list is powered by the following services:

Other Resources About Sophia Hober

What Schools Are Affiliated With Sophia Hober?

Sophia Hober is affiliated with the following schools:

Sophia Hober's Academic­Influence.com Rankings

Sophia Hober's Degrees

Similar Degrees You Can Earn

Why Is Sophia Hober Influential?

Sophia Hober's Published Works

Published Works

Other Resources About Sophia Hober

What Schools Are Affiliated With Sophia Hober?

Sophia Hober's AcademicInfluence.com Rankings